glp 1 agonist liver disease Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) for the management of nonalcoholic fatty (NAFLD): A systematic review - Lv - 2020 - Endocrinology, Diabetes & Metabolism Multiple target tissue effects of
Description
Kaastrup P

Diabetol Int 16 , 448456 (2025)

Now mind you, not all of this can be attributed to, you know, the medications themselves

JAMA Neurol 78:678686

Horm Mol Biol Clin Investig
Indeed, Australian guidelines recommend GLP-1RAs as an add-on option to metformin from the second-line setting (Fig
